PYMNTS.com August 5, 2024

The healthcare industry is witnessing a shift as artificial intelligence (AI) attracts massive investments and partnerships. Spring Health’s $3.3 billion valuation, CytoReason’s $80 million funding round, and the AWS-GE HealthCare collaboration highlight the growing confidence in AI’s potential to transform mental health services, accelerate drug discovery, and revolutionize patient care delivery.

Mental Health Tech’s $100M Boost

Spring Health, a New York-based mental health platform, recently secured a $100 million Series E funding round, pushing its valuation to a lofty $3.3 billion. The company’s platform uses artificial intelligence to match patients with appropriate care providers and treatment plans.

This latest financial injection, led by Generation Investment Management, underscores the growing appetite for innovative mental health solutions in the corporate world. Founded...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

Continue Reading

 
Topics: AI (Artificial Intelligence), Investments, Provider, Technology, Trends
Related Articles:
AI model uses ECGs to detect females at high risk of heart disease
Nvidia has teamed up with Utah to improve AI education and workforce training
AI reduces false positives by 37.3% in breast cancer diagnosis
Health IT hiring shifts to AI: 5 notes
The Physicians Make Decisions Act is AI Regulation Done Right

Share This Article